Professor Nazneen Rahman
Professor Nazneen Rahman is Head of the Division of Genetics and Epidemiology at The Institute of Cancer Research (ICR), London, Head of the Cancer Genetics Unit at The Royal Marsden NHS Foundation Trust, and Director of the TGLclinical gene testing laboratory at the ICR. She qualified in medicine from Oxford University in 1991, gained her CCST in Medical Genetics in 2001 and completed a PhD in Molecular Genetics in 1999.
Her research harnesses her scientific and clinical expertise to identify and clinically implement human disease genes. She has a strong focus on cancer predisposition genes, in which she is an internationally-recognised expert and has discovered many such genes during her career, particularly for breast, ovarian and childhood cancers.
Rahman is currently leading two innovative translational research programmes. The Mainstreaming cancer genetics (MCG) programme is undertaking the technological, scientific and translational work required to make cancer predisposition gene testing part of routine cancer care. The Transforming Genetic Medicine Initiative (TGMI) is building the knowledge base, tools and processes required to deliver the promise of genetic medicine.
Rahman has a strong commitment to open science and science communication and has garnered numerous awards, including a CBE in 2016 Queen’s birthday honours. In 2017, she was appointed as a Non-Executive Director for AstraZeneca’s Board of Directors and a member of the Science Committee. She is also a singer-songwriter.